Online COgnitive Behavioural Therapy for Sleep and Mental Health for Older Adults With Insomnia and Subjective Cognitive Complaints
Key facts
- Where
- Montreal and Ottawa, CanadaSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 60 and 99 years old?
Source: NCT06032377, who can take part
Where in Canada
- Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de l'Île-de-Montréal. CCSMTL - IUGMMontreal, CanadaContact: Florence Pomares, PhDTaking people
- The Royal's Institute of Mental Health Research (IMHR)Ottawa, CanadaContact: Rébecca Robillard, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
- Trial code
- NCT06032377
- Record updated
- 18 March 2026
- Original description
The goal of this randomized controlled clinical trial is to assess a novel cognitive-behavioral program for sleep and mental health using a multidomain web platform (eCBTi+) in participants with insomnia and subjective cognitive complaint. The main questions it aims to answer are:Read full original descriptionShow less
Improving Sleep to Protect Brain Health in Older Adults: Assessing a Novel Cognitive-behavioral Program for Insomnia Using a Multidomain Web Platform
The goal of this randomized controlled clinical trial is to assess a novel cognitive-behavioral program for sleep and mental health using a multidomain web platform (eCBTi+) in participants with insomnia and subjective cognitive complaint. The main questions it aims to answer are:
* Whether the eCBTi+ intervention improves sleep (subjective: Insomnia severity index [ISI], objective: EEG-based sleep efficiency) sleep and mental health (Geriatric Anxiety Index [GAI] and Geriatric Depression Scale [GDS]) compared to the control intervention * Whether the eCBTi+ intervention improves cognitive abilities (subjective: Cognitive Failure Questionnaire [CFQ], objective: CANTAB executive functions composite score) compared to the control intervention
Inclusion; age 60 years or older at the time of enrolment; Sleep Condition Indicator, SCI ≤ 16 and/or meeting DSM-V criteria based on the symptoms assessed by the SCI; subjective cognitive complaints (self-report version of Everyday Cognition scale (ECog), score ≥ 2 on any item); ability to read and understand French or English; ability to use a smartphone or tablet, and access to home internet connection; If on hypnotic or psychotropic medication (including cannabis), being on stable dosage for at least 2 months prior to study entry; Score on the STOP-BANG questionnaire < 3 corresponding to participants with low risk of obstructive sleep apnea; Exclusion; located outside of Québec or Ontario; current hospitalization or planned major surgery; uncorrected severe hearing or vision impairment; reported diagnosis of major neurocognitive disorder or mild cognitive impairment (MCI); performance suggestive of major neurocognitive disorder or MCI on T-MoCA < 17; reported diagnosis of schizophrenia or bipolar disorder; reported diagnosis or positive screen on the MINI for psychotic or bipolar disorders; high suicidal risk, as assessed by the modified Columbia-Suicide Severity Rating Scale; reported diagnosis or positive screening (apnea-hypopnea index >30 on a level 3 home sleep apnea test) for another untreated sleep disorder (e.g., sleep disordered breathing (OSA), REM sleep behavior disorder (RBD), restless legs syndrome (RLS); individuals with treated and controlled OSA (residual apnea-hypopnea index <30 and good therapeutic compliance) or RLS will not be excluded; current shift work; currently receiving CBT, having received CBTi in the past; frequent alcohol consumption having an impact on functionning (>10 glasses/week and having a significant impact on functionning); illicit drugs use (more than once a month); Additional exclusion criteria for neuroimaging; psychotropic (including hypnotic) medication in the past 2 weeks; contraindications for MRI (e.g., pacemaker, metallic implant, claustrophobia); unable or unwilling to come to one of the participating MRI centers (Montreal, Ottawa); medical conditions likely to affect sleep; in particular:; current neurological disorder (e.g., epilepsy with any seizure in the past year, concussion in the past 3 months, multiple sclerosis, Parkinson's disease); past history of brain lesion (e.g., brain hemorrhage, brain tumor, any condition having required brain surgery); major surgery (i.e., requiring general anesthesia) in the past 3 months; untreated thyroid disorder; chronic pain syndrome self-reported as interfering with sleep (e.g., migraine, fibromyalgia, rheumatoid arthritis); recent and severe infection in the past 3 months (e.g., pneumonia, kidney infection); active cancer or treated cancer with post-cancer treatment for less than 2 years; Inclusion/exclusion criteria for good sleepers Twenty-five good sleepers without cognitive complaint will be recruited as controls for the MRI session following the same criteria described above, except that SCI ≥ 17, not meeting the diagnostic criteria for chronic insomnia as assessed by the insomnia module of the SCID and no subjective cognitive complaint.